Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

How AstraZeneca Overcame US Anti-Trust Obstacles For Alexion Deal

CFO Confident Of Closing In Q3

Apr 22 2021

• By Kevin Grogan

obstacle — FTC proved no obstacle for AstraZeneca • Source: Alamy

Related Content

US, EU and UK Antitrust Enforcers Form Pharma Monitoring Taskforce

Mar 17 2021

Related Companies

AstraZeneca PLC

Alexion Pharmaceuticals Inc.

Additional Topics

M & A Strategy Rare Diseases Leadership BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.